Vaseretic Tablet
NDC Package 0187-0146-01
Package Information
Vaseretic (enalapril maleate and hydrochlorothiazide) tablets is a medication used to treat high blood pressure (hypertension). This formulation utilizes a tablet delivery system. Marketed by Bausch Health Us, Llc, this product is identified by NDC 0187-0146 and is authorized under FDA application NDA019221.
Identification & Billing
- RxCUI: 858828 - enalapril maleate 10 MG / hydroCHLOROthiazide 25 MG Oral Tablet
- RxCUI: 858828 - enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet
- RxCUI: 858828 - enalapril maleate 10 MG / HCTZ 25 MG Oral Tablet
- RxCUI: 858830 - Vaseretic 10 MG / 25 MG Oral Tablet
- RxCUI: 858830 - enalapril maleate 10 MG / hydrochlorothiazide 25 MG Oral Tablet [Vaseretic]
Clinical Specifications
- Angiotensin Converting Enzyme Inhibitor - [EPC] (Established Pharmacologic Class)
- Angiotensin-converting Enzyme Inhibitors - [MoA] (Mechanism of Action)
- Decreased Blood Pressure - [PE] (Physiologic Effect)
- Increased Diuresis - [PE] (Physiologic Effect)
- Thiazide Diuretic - [EPC] (Established Pharmacologic Class)
- Thiazides - [CS]
Regulatory & Marketing
Hierarchy Structure
- 0187 - Bausch Health Us, Llc
- 0187-0146 - Vaseretic
- 0187-0146-01 - 100 TABLET in 1 BOTTLE
- 0187-0146 - Vaseretic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0187-0146-01 identifies a specific commercial package of 100 tablet in 1 bottle of Vaseretic, a human prescription drug labeled by Bausch Health Us, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains enalapril maleate; hydrochlorothiazide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch Health Us, Llc on October 31, 1986. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains 2 medications, enalapril and hydrochlorothiazide. Enalapril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so that blood can flow through the body more easily. Hydrochlorothiazide is a "water pill" (diuretic) and causes your body to get rid of extra salt and water. This effect may increase the amount of urine you make when you first start the medication. It also helps to relax the blood vessels so that blood can flow through the body more easily.
How is this Bausch Health Us, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00187014601. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.